1. Home
  2. Stocks
  3. Thyrocare Share Price

Thyrocare Technologies Share Price

Healthcare Mid Cap

₹959.35 -11.2 (-1.15%)

05 Nov, 2024 22:05

SIP TrendupStart SIP in THYROCARE

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹941
  • High
  • ₹981
  • 52 Week Low
  • ₹534
  • 52 Week High
  • ₹985
  • Open Price₹965
  • Previous Close₹971
  • Volume80,510

Investment Returns

  • Over 1 Month + 19.28%
  • Over 3 Month + 18.32%
  • Over 6 Month + 52.02%
  • Over 1 Year + 74.59%
SIP Lightning

Smart Investing Starts Here Start SIP with Thyrocare Technologies for Steady Growth!

Thyrocare Technologies Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 60.5
  • PEG Ratio
  • 2.1
  • Market Cap Cr
  • 5,082
  • P/B Ratio
  • 9.6
  • Average True Range
  • 41.75
  • EPS
  • 13
  • Dividend Yield
  • 1.9
  • MACD Signal
  • 24.04
  • RSI
  • 65.04
  • MFI
  • 71.31

Thyrocare Technologies Financial

IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations163.05143.63141.23122.89136.29
Total Income From Operations163.05143.63141.23122.89136.29
P/L Before Interest, Excpt. Items & Tax40.9736.0725.9921.7229.15
P/L Before Exceptional Items & Tax40.3435.1425.0520.7628.13
P/L After Tax from Ordinary Activities29.5925.1519.2314.8920.29
Net Profit/Loss For the Period29.5925.1519.2314.8920.29
IndicatorMar 24Mar 23
Revenue From Operations [Gross]520.29477.62
Revenue From Operations [Net]520.29477.62
Total Operating Revenues524.02486.46
Total Revenue531.20491.85
Total Expenses432.98410.78
Profit/Loss Before Tax98.2281.07
Profit/Loss For The Period71.1456.97
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity155.19120.02
Net Cash Used In Investing Activity-80.29-31.65
Net Cash Used in Finance Activity-83.71-87.50
Net Inc/Dec In Cash And Equivalent-8.810.87
Cash And Equivalent End Of Year3.5612.37
IndicatorMar 24Mar 23
Total Share Capital52.9552.93
Total Non-Current Liabilities30.5017.63
Total Current Liabilities75.9673.20
Total Capital And Liabilities620.27611.87
Total Non-Current Assets374.62376.50
Total Current Assets245.65235.37
Total Assets620.27611.87
Indicator20242023
EBIT Margin (%)19.4517.12
Return On Capital Employed (%)18.7315.46
Return On Equity (%)13.8410.93
Long Term Debt To Equity (%)2.120.00
Book Value/Share (INR)97.0498.44
IndicatorSep 24Jun 24Mar 24Dec 23Sep 23
Net Sales/Income from operations177.36156.91154.25134.74148.00
Total Income From Operations177.36156.91154.25134.74148.00
P/L Before Interest, Excpt. Items & Tax37.8234.9024.2420.8529.04
P/L Before Exceptional Items & Tax37.0633.9123.1219.7827.91
P/L After Tax from Ordinary Activities26.7124.3017.4014.6119.97
Net Profit/Loss For the Period26.7124.3017.4014.6119.97
IndicatorMar 24Mar 23
Revenue From Operations [Gross]567.88517.20
Revenue From Operations [Net]567.88517.20
Total Operating Revenues571.88526.67
Total Revenue581.25535.09
Total Expenses485.66447.68
Profit/Loss Before Tax95.5987.41
Profit/Loss For The Period69.1063.18
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity167.63129.31
Net Cash Used In Investing Activity-91.28-38.99
Net Cash Used in Finance Activity-84.81-86.18
Net Inc/Dec In Cash And Equivalent-8.464.14
Cash And Equivalent End Of Year9.3017.77
IndicatorMar 24Mar 23
Total Share Capital52.9552.93
Total Non-Current Liabilities25.7720.40
Total Current Liabilities90.4877.10
Total Capital And Liabilities643.88632.72
Total Non-Current Assets365.37359.78
Total Current Assets278.51272.94
Total Assets643.88632.72
Indicator20242023
EBIT Margin (%)17.4417.04
Return On Capital Employed (%)18.0316.15
Return On Equity (%)13.4312.04
Long Term Debt To Equity (%)2.070.00
Book Value/Share (INR)99.65101.12

Thyrocare Technologies Technicals

EMA & SMA

Current Price
₹959.35
-11.2 (-1.15%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹905.96
  • 50 Day
  • ₹864.03
  • 100 Day
  • ₹810.84
  • 200 Day
  • ₹742.37

Resistance and Support

960.57 Pivot Speed
  • R3 1,020.48
  • R2 1,000.92
  • R1 980.13
  • S1 939.78
  • S2 920.22
  • S3 899.43

Is Thyrocare Technologies Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Thyrocare Technologies Ltd. is one of India’s leading diagnostic and preventive healthcare service providers, specializing in affordable and reliable pathology tests, including thyroid, diabetes, and wellness profiles, with a nationwide network of diagnostic labs and collection centers. Thyrocare Technologies has an operating revenue of Rs. 623.26 Cr. on a trailing 12-month basis. An annual revenue growth of 9% is good, Pre-tax margin of 17% is great, ROE of 13% is good. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 8% and 32% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 4% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 55 which is a POOR score indicating inconsistency in earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 29 indicates it belongs to a strong industry group of Medical-Services and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Thyrocare Technologies Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-10-23 Quarterly Results
2024-07-23 Quarterly Results
2024-05-14 Audited Results & Final Dividend
2024-02-01 Quarterly Results
2023-10-31 Quarterly Results
Date Purpose Remarks
2024-08-16 FINAL Rs.18.00 per share(180%)Final Dividend
2023-04-20 INTERIM Rs.18.00 per share(180%)Interim Dividend
2022-05-12 FINAL Rs.15.00 per share(150%)Interim Dividend

Thyrocare Technologies F&O

Thyrocare Technologies Shareholding Pattern

71.11%
12.9%
1.08%
1.93%
0%
9.78%
3.2%
  • NSE Symbol
  • THYROCARE
  • BSE Symbol
  • 539871
  • Managing Director & CEO
  • Mr. Rahul Guha
  • ISIN
  • INE594H01019

Thyrocare Technologies FAQs

Thyrocare Technologies share price is ₹959 As on 05 November, 2024 | 21:51

The Market Cap of Thyrocare Technologies is ₹5081.9 Cr As on 05 November, 2024 | 21:51

The P/E ratio of Thyrocare Technologies is 60.5 As on 05 November, 2024 | 21:51

The PB ratio of Thyrocare Technologies is 9.6 As on 05 November, 2024 | 21:51

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.